Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

In partnership with CEL-SCI Corporation, Northeast Ohio Medical University (NEOMED) has produced a new investigational breast cancer vaccine. In animal tests the J-HER vaccine has shown reduction of HER-2/neu expressing breast cancer tumors, reduction mass, absence of tumor in lymph nodes or peritoneal membranes, and changes in angiogenesis.

Dr. Rosenthal, Sarah Stone and Robin Edmonds from NEOMED worked with CEL-SCI’s Dr. Daniel Zimmerman to design and test the LEAPS (Ligand Epitope Antigen Presentation System) technology vaccine. 

Present in most human breast tumor cells, the HER-2/neu protein is the target for different types of immunotherapy with sales of many billions of dollars.  Blocking this receptor protein with an antibody causes the tumor cells to commit suicide, or apoptosis. The J-HER vaccine activates a T lymphocyte response targeted to this protein that promotes killing and control of the tumor cell. In these studies, mice were immunized with the vaccine before, or one week after implantation of HER-2/neu breast cancer cells. In both cases the immune response initiated by the immunization significantly blocked further development and progression of tumors in most of the animals.

More details on the vaccine and technology available here.

NEOMED is located in Rootstown, Ohio. CEL-SCI has operations in Vienna, Virginia, and Baltimore, Maryland.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Thermalin Diabetes raises $5.9M to support development of highly concentrated, rapid-acting insulin | MedCity News, July 29, 2014

CWRU summer biomedical program, in 13th year, transforms high school students into scientists | Cleveland.com, July 28, 2014

Cleveland helping to power a growing Midwest bioscience industry, study shows | Cleveland.com, July 28, 2014

Why Abbott Labs’ Tipp City plant is a bigger deal than you probably realize | Dayton Business Journal, July 25, 2014

AtriCure shares leaped in early trading after posting quarterly results that beat analysts’ expectations | Cincinnati Business Journal, July 25, 2014

Dee Ellingwood, former senior VP at Cincinnati Children’s Hospital Medical Center, joins Meridian Bioscience board of directors | Cincinnati Business Courier, July 25, 2014

University of Cincinnati President Santa Ono keeping busy during summer | Cincinnati Business Courier, July 25, 2014

Lab Chat: Discussing personalized treatments for cancer with Cleveland Clinic’s Dr. Mohamed Abazeed | Fresh Water Cleveland, July 24, 2014

ChanTest announces newly validated and re-engineered cells, expands portfolio of ion channel and GPCR cell lines | PR Web, July 24, 2014

OsteoSymbionics, makers of facial reconstruction products, profiled in Fresh Water Cleveland | Fresh Water Cleveland, July 24, 2014

Advanced Biological Marketing to expand production facility in Van Wert | Toledo Blade, July 24, 2014

CTI Clinical Trial and Consulting Services promotes two and adds six to their team | Cincinnati.com, July 24, 2014

Dayton Children’s Hospital featured in 2014 Google economic impact study for use of Google to attract new patients, inform, educate families | , July 24, 2014

Center for Disruptive Musculoskeletal Innovations formed by the NSF, UC San Francisco and Univeristy of Toledo | UCSF, July 24, 2014

Ohio State University’s Wexner Medical Center performs its 400th heart transplant | Columbus Dispatch, July 23, 2014

Akron Children’s Hospital leading research to standardize and improve safety for patient transfers | Columbus CEO, July 23, 2014

Juventas Therapeutics strengthens leadership team by adding two industry veterans as CFO and CSO | PR Newswire, July 23, 2014

Akron Children’s Hospital to broadcast “Bridging the Gap in Concussion Treatment” training event | Ohio.com, July 23, 2014

LabTV to work with The Ohio State University’s research scientists | WebWire, July 23, 2014

Cincinnati based CTI Clinical Trial and Consulting Services opens office in Sao Paulo, Brazil | Cincinnati.com, July 22, 2014